Medical Research News

RSS

Physicians of Orthopaedic & Spine Center open new Pain Management Center at Virginia

The physicians of Orthopaedic & Spine Center have announced the opening of their new Pain Management Center, located at 250 Nat Turner Boulevard in Newport News, Virginia. In its sixth year, the pain management program now has its own dedicated space on the second floor.

20 Aug 2014

5 ways to fight Lewy body dementia

Today, the Lewy Body Dementia Association (LBDA) steps up its awareness and fundraising effort "Lewy Who?" to put the brakes on Lewy body dementia (LBD). With symptoms that resemble both Alzheimer's and Parkinson's disease, LBD is the most misdiagnosed form of dementia.

20 Aug 2014

QuitCash Challenge gives Minnesota smokers incentive to quit by offering $5,000 grand prize

QUITPLAN® Services is bringing back the popular QuitCash Challenge, with a new twist. Now, to help tobacco users prepare for the month-long quit and win contest coming in May, several shorter practice quit challenges will be held in the coming months, starting at the State Fair.

20 Aug 2014

Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and initiation of IND enabling studies of a novel clinical development candidate, GBR 1302, a HER2xCD3 bispecific antibody.

20 Aug 2014

Researchers find that same desire for intimacy is strong predictor for PrEp HIV prevention

Men in steady same-sex relationships where both partners are HIV negative will often forgo condoms out of a desire to preserve intimacy, even if they also have sex outside the relationship.

20 Aug 2014

Study underscores the importance of newborn screening for Bubble Boy disease

The Immune Deficiency Foundation (IDF) applauds a new study published August 19, 2014 in the Journal of the American Medical Association that underscores the importance of newborn screening for Severe Combined Immune Deficiency (SCID), also known as Bubble Boy disease.

20 Aug 2014

Study explores the effectiveness of stents in treating vein obstructions

Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat blocked veins. For years, stents - small mesh tubes - have been used to treat narrowed or blocked arteries; however none are specifically designed for use in veins.

20 Aug 2014

Case study from Intel and UCSD highlights health sciences research

A case study from Intel and UCSD highlights the transformative collaboration between the school's bioengineering department and the Intel® Internet of Things (IoT).

20 Aug 2014

Seafood mislabeling can cause unwanted exposure to harmful pollutants

New measurements from fish purchased at retail seafood counters in 10 different states show the extent to which mislabeling can expose consumers to unexpectedly high levels of mercury, a harmful pollutant.

20 Aug 2014

Researchers examine China's caesarean section rate

Efforts must be made to decrease China's increasing caesarean section rate, suggests a new commentary published today (20 August) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

20 Aug 2014

Hartford/VA Scholars Program selects three geriatric social work researchers

The prestigious Hartford/VA Scholars Program has selected three geriatric social work researchers for a two-year award that provides career development and mentorship for projects that will improve health outcomes not only for older veterans, but for all older adults.

20 Aug 2014

Scientists suggest that type-1 and type-2 diabetes are result of same mechanism

Work by scientists at the Universities of Manchester and Auckland suggest that both major forms of diabetes are the result of the same mechanism.

From The University of Manchester 20 Aug 2014

Longitude and NovaQuest acquire California Cryobank

California Cryobank, a global leader in reproductive tissue donor services and storage and stem cell banking, announced today that it has been acquired by equity investors Longitude Venture Partners II, L.P. and NovaQuest Pharma Opportunities Fund III, L.P..

20 Aug 2014

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Some infants born with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have a more difficult time going through withdrawal than others, but the underlying reasons are not well understood.

20 Aug 2014

Researchers treat common elastic bands with graphene to create flexible sensor for medical use

Although body motion sensors already exist in different forms, they have not been widely used due to their complexity and cost of production.

20 Aug 2014

Analysis of Candida glabrata fungus mutations reveals new genes that confer anti-fungal tolerance

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans.

20 Aug 2014

Study measures quality indicators in cardiac rehabilitation programs across Canada

The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Centre, York University and UHN.

20 Aug 2014

Study: 15,000 pregnant women show decreased amount of prevalence of HSV type 2

In a study that included approximately 15,000 pregnant women, seroprevalence of herpes simplex virus (HSV) type 2 decreased substantially between 1989 and 2010 while there was no overall decrease for HSV type 1, but a slight increase among black women, according to a study in the August 20 issue of JAMA.

20 Aug 2014

Study examines national impact of newborn screening test for SCID

Severe combined immunodeficiency (SCID), a potentially life-threatening, but treatable, disorder affecting infants, is twice as common as previously believed, according to a new study that is the first to examine the national impact of this newborn screening test.

20 Aug 2014

KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME.

20 Aug 2014

Medical Research News

Physicians of Orthopaedic & Spine Center open new Pain Management Center at Virginia

5 ways to fight Lewy body dementia

QuitCash Challenge gives Minnesota smokers incentive to quit by offering $5,000 grand prize

Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Researchers find that same desire for intimacy is strong predictor for PrEp HIV prevention

Study underscores the importance of newborn screening for Bubble Boy disease

Study explores the effectiveness of stents in treating vein obstructions

Case study from Intel and UCSD highlights health sciences research

Seafood mislabeling can cause unwanted exposure to harmful pollutants

Researchers examine China's caesarean section rate

Hartford/VA Scholars Program selects three geriatric social work researchers

Scientists suggest that type-1 and type-2 diabetes are result of same mechanism

Longitude and NovaQuest acquire California Cryobank

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Researchers treat common elastic bands with graphene to create flexible sensor for medical use

Analysis of Candida glabrata fungus mutations reveals new genes that confer anti-fungal tolerance

Study measures quality indicators in cardiac rehabilitation programs across Canada

Study: 15,000 pregnant women show decreased amount of prevalence of HSV type 2

Study examines national impact of newborn screening test for SCID

KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News